Enteroscopy for the early detection of small bowel tumours in at-risk celiac patients

Dig Liver Dis. 2014 May;46(5):400-4. doi: 10.1016/j.dld.2013.12.009. Epub 2014 Jan 15.

Abstract

Background: A subset of celiac patients shows a high risk for small bowel malignancies.

Aims: To select celiac patients considered at risk and evaluate the diagnostic yield of enteroscopy in this context.

Methods: Celiac patients were enrolled from a tertiary referral centre during the period June 2011-June 2013, based on the following criteria: (i) patients diagnosed when aged 50+ and with poor response to gluten-free dieting; (ii) low dietary compliance; (iii) alarm symptoms. The patients underwent small bowel capsule endoscopy and/or double-balloon enteroscopy. Control populations were represented by the 165 non-celiac patients undergoing capsule endoscopy for obscure gastrointestinal bleeding, and the 815,362-strong population of the Italian province of Varese as a registered cohort.

Results: Fifty-three patients (19% males, mean age 43.6±17.4 years) were evaluated. Two jejunal adenocarcinomas and one ileal neuro-endocrine tumour were diagnosed by enteroscopy (the diagnostic yield for malignancies in the selected population being 5.7%). In the non-celiac controls the detection rate of small bowel tumours by capsule endoscopy was 0.6% (P=0.04). When compared to the registered population, the relative risk for intestinal malignancy was 1282 (95% CI, 407-4033; P<0.0001).

Conclusions: Capsule endoscopy and double-balloon enteroscopy can be considered for early disease management of a subset of celiac patients.

Keywords: Celiac disease; Enteroscopy; Malignancies; Small bowel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adult
  • Anemia / etiology
  • Capsule Endoscopy*
  • Celiac Disease / complications*
  • Double-Balloon Enteroscopy* / adverse effects
  • Early Detection of Cancer / methods
  • Female
  • Humans
  • Ileal Neoplasms / diagnosis*
  • Jejunal Neoplasms / diagnosis*
  • Male
  • Middle Aged
  • Neuroendocrine Tumors / diagnosis*
  • Patient Selection
  • Prospective Studies
  • Risk Factors